Cangrelor antiplatelets drug  

AR-C69931MX - AR C69931MX      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultcardiovascular eventsCardiovascular death

acute coronary syndrome  

CHAMPION-PCI, 2009      NCTcangrelor up frontclopidogrel up frontLow risk of bias negative4%
CHAMPION-PLATFORM, 2009    NCTcangrelor up frontdelayed clopidogrelLow risk of bias negative-13%

percutaneous coronary intervention  

CHAMPION PHOENIX, 2013        NCTcangrelorclopidogrelLow risk of bias suggesting-20%0%
CHAMPION-PCI, 2009      NCTcangrelor up frontclopidogrel up frontLow risk of bias negative4%
CHAMPION-PLATFORM, 2009    NCTcangrelor up frontdelayed clopidogrelLow risk of bias negative-13%